Traduire
Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022
NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire
Spreading safe, cheap embolization around the world
Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice
R&D
Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.
Services
CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.
Training
Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.
Recent Posts
-
Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 - 3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
- FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
- Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
- Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Dernières Publications (5/364)
- Pepponi, M, Berti, V, Fasciglione, E, Montanini, F, Canu, L, Hubele, F et al.. [68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06735-5. PubMed PMID:38687372 .
- Van Weehaeghe, D, Lapauw, B, Fraioli, F, Cecchin, D, Verger, A, Guedj, E et al.. EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06728-4. PubMed PMID:38687371 .
- Dubois, J, Tosato, G, Garrigue, P, Taieb, D, Guillet, B, Nail, V et al.. Short-Term Biological Toxicity Prediction of [177Lu]Lutetium-Oxodotreotide: An Original Retrospective Analysis. Cancer Biother Radiopharm. 2024; :. doi: 10.1089/cbr.2023.0195. PubMed PMID:38655905 .
- Baylot, V, Le, TK, Taïeb, D, Rocchi, P, Colleaux, L. Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs. Commun Biol. 2024;7 (1):489. doi: 10.1038/s42003-024-06121-9. PubMed PMID:38653753 PubMed Central PMC11039704.
- Jha, A, Patel, M, Ling, A, Shah, R, Chen, CC, Millo, C et al.. Diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma. Eur Radiol. 2024; :. doi: 10.1007/s00330-024-10652-4. PubMed PMID:38625612 .